首页> 外文期刊>Frontiers in Pharmacology >Tanshinones, Critical Pharmacological Components in Salvia miltiorrhiza
【24h】

Tanshinones, Critical Pharmacological Components in Salvia miltiorrhiza

机译:丹参酮,在<斜体>丹参中的关键药理组分

获取原文
           

摘要

Salvia miltiorrhiza Bunge, a member of the Lamiaceae family, is valued in traditional Chinese Medicine. Its dried root (named Danshen) has been used for hundreds of years, primarily for the treatment of cardiovascular and cerebrovascular diseases. Tanshinones are the main active ingredients in S. miltiorrhiza and exhibit significant pharmacological activities, such as antioxidant activity, anti-inflammatory activity, cardiovascular effects, and antitumor activity. Danshen dripping pill of Tianshili is an effective drug widely used in the clinical treatment of cardiovascular diseases. With the increasing demand for clinical drugs, the traditional method for extracting and separating tanshinones from medicinal plants is insufficient. Therefore, in combination with synthetic biological methods and strategies, it is necessary to analyze the biosynthetic pathway of tanshinones and construct high-yield functional bacteria to obtain tanshinones. Moreover, the biosynthesis of tanshinones has been studied for more than two decades but remains to be completely elucidated. This review will systematically present the composition, extraction and separation, pharmacological activities and biosynthesis of tanshinones from S. miltiorrhiza , with the intent to provide references for studies on other terpenoid bioactive components of traditional Chinese medicines and to provide new research strategies for the sustainable development of traditional Chinese medicine resources.
机译:萨尔维亚米尔蒂氏崎山丘,Lamiaceae家族成员,在中医中有价值。它的干燥根(命名Danshen)已被使用数百年,主要用于治疗心血管和脑血管疾病。丹参酮是S. Miltiorrhiza的主要活性成分,并且表现出显着的药理学活动,例如抗氧化活性,抗炎活性,心血管作用和抗肿瘤活性。天鹅滴水丸是一种有效的药物,广泛用于心血管疾病的临床治疗。随着对临床药物的需求不断增加,传统的提取和分离药用植物的丹参酮的方法是不充分的。因此,与合成生物方法和策略组合,有必要分析丹石松的生物合成途径,并构建高产功能细菌以获得丹参酮。此外,已经研究了丹参酮的生物合成超过二十年,但仍有待完全阐明。本综述系统将系统地提出来自S. Miltiorrhiza的丹参酮的组成,提取和分离,药理活性和生物合成,其中目的是提供关于中药其他三萜类生物活性成分的研究以及为可持续发展提供新的研究策略中医资源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号